Alyeska Investment Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Alyeska Investment Group’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-485,917	Closed	-$675K	–	646
2015 Q1	$675K	Buy	+485,917	New	+$675K	0.01%	456

Alyeska Investment Group's RXII Position: Q2 2015 in Review

Alyeska Investment Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q2 2015, closing a stake of 485,917 shares — an estimated $675K sold.

Alyeska Investment Group first reported a position in RXII in Q1 2015 and held it in 1 quarter. The position peaked at $675K in Q1 2015. 86 funds tracked by Wall St. Rank hold RXII as of Q2 2015.

Alyeska Investment Group reported no remaining GALENA BIOPHARMA INC COM position as of Q2 2015 after selling out during the quarter.
Alyeska Investment Group sold 485,917 GALENA BIOPHARMA INC COM shares in Q2 2015, an estimated $675K.
Alyeska Investment Group first reported a position in GALENA BIOPHARMA INC COM in Q1 2015 and held it in 1 quarter.
Alyeska Investment Group's GALENA BIOPHARMA INC COM position peaked at $675K in Q1 2015.
86 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q2 2015.

Based on Alyeska Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.